Stay updated on Pembrolizumab Combo in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in mCRPC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The change in the value represents an update in the study record for the Phase 3 study of pembrolizumab plus docetaxel for metastatic castration-resistant prostate cancer. The revision to v2.9.0 includes details about the study plan, collaborators, investigators, publications from PubMed, study record dates, and more information.
    Difference
    3%
    Check dated 2024-06-21T04:07:12.000Z thumbnail image
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    8 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.0%
    Check dated 2024-06-13T21:48:32.000Z thumbnail image
  6. Check
    15 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in the study record details of a Phase 3 clinical trial evaluating the combination of pembrolizumab and docetaxel in the treatment of metastatic castration-resistant prostate cancer.
    Difference
    0.0%
    Check dated 2024-06-06T14:24:12.000Z thumbnail image
  7. Check
    30 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed eligibility criteria for participants, including specific inclusion and exclusion criteria for the study. Previously, this section only indicated that no information was provided.
    Difference
    18%
    Check dated 2024-05-22T20:22:25.000Z thumbnail image
  8. Check
    51 days ago
    Change Detected
    Summary
    The value 'Go to the classic website' has been updated to 'Site Map'. This change likely represents a modification in the navigation options available on the webpage.
    Difference
    0.4%
    Check dated 2024-05-01T21:46:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.